310.274.7422
9001 Wilshire Blvd, Suite 305, Beverly Hills, CA 90211
  • The Leading Expert in

    Eyelid & Cosmetic Surgery

Kybella Beverly Hills

“Put your best chin forward.” Dr. Steinsapir is offering the only FDA-approved injectable treatment for the fat under the chin. Kybella® permanently destroys the fat for a long lasting improvement in the chin profile without surgery. Kybella® is safe and effective for treatment of moderate to severe fat below the chin which is also know and submental fat. In our office, Dr. Steinsapir will administer your treatement. Many patients benefit from just one or two treatment sessions spaced 4 to 6 weeks apart. Additional treatments may be necessary.

Dr. Steinsapir offers state of the art neck liposuction. However, not everyone is comfortable with the idea of surgery. Dr. Steinsapir offers Kybella, the first nonsurgical alternative to neck liposuction for addressing stubborn submental fat commonly called a double chin. The active ingredient in Kybella is a synthetic deoxycholic acid. That is a molecule that naturally occurs in the body that brakes down fat in the diet. Careful studies showed that this same agent can be injected into fat to permanently removed unwanted fat. The allows the fullness under the chin to be treated nonsurgically.

How is treatment done?

Dr. Steinsapir is a Kybella trained physician. At your initial visit, he will review your goals, discuss how treatment is performed, what is anticipated, and the potential risk associated with treartment. After deciding to go forward with treatment, the skin under the chin is numbed. Then you receive multiple small injections under the chin. The procedure takes about 20 minutes.

How many treatments are needed.

Everyone’s area under the chin is a bit different. Many patients need 2 to 3 treatments at 6 week intervals to achieve their goal. A good number of individuals need up to 6 treatments. Clinical studies find that 59% of patients receive 6 treatments.

What can I expect after treatment?

You will have swelling and you may have brusing. The swelling varies but it can be significant (“Doc, I am surprised how swollen I am.”). So be prepared. The swelling often peaks at about 24 hours after the procedure. Many people find it completely feasible to have service on a Thursday or Friday and be okay to return to work on Monday. The treated area is uncomfortable for the first 8 hours and we recommend Tylenol or something stronger. Icing is also helpful for comfort. The area will be tender to touch. This inflammation is what removes the unwanted fat. Some patients will report discomfort swallowing or horseness in the first 12 hours. Breathing is not affected and drinking soft foods and liquids is unaffected. The swelling present at 24 hours begins to subside. The texture of the chin fat changes and feels firm (lumpy/bumpy). You feel this but it is not visible in the skin. What is going on here is inflammation that will remove the unwanted fat over a period of weeks. The area can also feel somewhat numb here and there is decreased sensation in the treated area. This recovers but it can take time. It takes about a month to see an improved neck contour from a given treatment. It is best to wait a full 6 weeks in Dr. Steinsapir’s opinon before having the next treatment. This allows time to assess how you have done and this makes it possible to achieve your goals with fewer treatments.

What information do I need to provide for my treatment?

Dr. Steinsapir takes your health seriously. We will talk to you about your medical history including if you have had or plan to have face, neck, or chin surgery or other treatments, have a history of trouble swallowing, easy bruisability or bleeding problems, including taking a blood thinner like Plavix or Coumadin, if you are pregnant, plan to become pregnant or are breast feeding, your medication history and any drug allergies.

I would like to go forward and have Kybella treatment with Dr. Steinsapir. How do I proceed?

Call the office at (310)274-7422 and ask to schedule a consultation with Dr. Steinsapir for your Kybella treatment. If you might have service at the time of the consultation, an option many choose, the office will schedule you accordingly. We recommend avoiding things that can thin the blood for about 10 days before treatment. The office will discuss this with you when you schedule. At your consult, Dr. Steinsapir will personally review your information, discuss any concerns so you can decide if treatment is right for you. If you choose, treatment can be performed at the time of the consultation, starting you on the path to a better and more youthful chin without surgery.

KYBELLA® (deoxycholic acid) injection 10 mg/mL
Indication and Important Safety Information

KYBELLA® (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.

The safe and effective use of KYBELLA® for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.

Contraindications
KYBELLA® is contraindicated in the presence of infection at the injection sites.

Warnings and Precautions
Marginal Mandibular Nerve Injury
Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness, were reported in 4% of subjects in the clinical trials; all cases resolved spontaneously (range 1-298 days, median 44 days). KYBELLA® should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.

Dysphagia
Dysphagia occurred in 2% of subjects in the clinical trials in the setting of administration-site reactions, eg, pain, swelling, and induration of the submental area; all cases of dysphagia resolved spontaneously (range 1-81 days, median 3 days). Avoid use of KYBELLA® in patients with current or prior history of dysphagia as treatment may exacerbate the condition.

Injection-Site Hematoma/Bruising
In clinical trials, 72% of subjects treated with KYBELLA® experienced hematoma/bruising. KYBELLA® should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur.

Risk of Injecting Into or in Proximity to Vulnerable Anatomic Structures
To avoid the potential of tissue damage, KYBELLA® should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles.

Adverse Reactions
The most commonly reported adverse reactions in the pivotal clinical trials were: injection site edema/swelling, hematoma/bruising, pain, numbness, erythema, and induration.

Dr. Steinsapir will provide more information regarding Kybella®, assess if you are a candidate for treatment, and answer your questions at the time of your personal consultation.